Skip to product content

ACTIVE PHARMACEUTICAL INGREDIENT

Nilotinib API

Review Nilotinib API records for sourcing and regulatory due diligence. Compare FDA Drug Master File holders and activity codes, then check the chemical form and identifiers before requesting documentation.

Complete data requires an active subscription. Already subscribed? Sign in to access your data.

This profile uses the free-base identity, CAS 641571-10-0. FDA records are selected by reported subject. The workbook has no CAS field to verify the chemical form of an individual filing.

Nilotinib registration data overview

The supplied FDA snapshot contains 4 Type II records with the subject NILOTINIB. Browse the free sample or subscribe to search, filter and export the complete set.

The counts describe filings at the snapshot cutoff. Confirm the current activity status with FDA and the material specification with the holder before relying on a record.

Personal API data subscription

$19.00 per month

$149.00 per year

Billed $149.00 every year

Nilotinib coverage: 4 FDA DMF records. The free CSV sample contains the preview rows.

Subscription benefits and CSV samples
  • Complete available registry records
  • Search and status filters
  • Documented company-name correspondences
  • CSV exports with sources

One personal account can access subscription datasets currently available on APIRFQ. Coverage varies by product.

US REGULATORY RECORDS

Nilotinib FDA Drug Master Files

Compare DMF numbers, reported holders, initial submission dates and activity status. The holder name identifies the party listed in the filing. Confirm the manufacturing site separately during qualification.

FDA DMF records: 4. Distinct reported holders: 4.

3Active (A)

1Inactive (I)

FDA uses A for active and I for inactive. An active entry alone does not establish permission to reference the file, an approved supplier or an available batch.

Free previewShowing 3 sample records of 4.

  • SICHUAN XIELI PHARMACEUTICAL CO LTDDMF number 26497Inactive (I)Record details
    DMF number
    26497
    Activity status
    Inactive (I)
    DMF type
    II
    Initial submission
    2012-09-28
    Reported holder
    SICHUAN XIELI PHARMACEUTICAL CO LTD
    Reported subject
    NILOTINIB
  • MSN LABORATORIES PRIVATE LTDDMF number 33196Active (A)Record details
    DMF number
    33196
    Activity status
    Active (A)
    DMF type
    II
    Initial submission
    2018-09-29
    Reported holder
    MSN LABORATORIES PRIVATE LTD
    Reported subject
    NILOTINIB
  • SHILPA PHARMA LIFESCIENCES LTDDMF number 36289Active (A)Record details
    DMF number
    36289
    Activity status
    Active (A)
    DMF type
    II
    Initial submission
    2021-09-21
    Reported holder
    SHILPA PHARMA LIFESCIENCES LTD
    Reported subject
    NILOTINIB

Free preview

More records available with a subscription: 1.

Inclusion criteria
  • Included 4 Type II entries whose subject equals NILOTINIB after trimming whitespace for selection. Subjects that name a salt, hydrate or premix are excluded.
  • All six FDA fields and their original values are retained, with Excel submission dates converted to ISO format. Activity codes describe the June 30, 2026 snapshot.

Nilotinib chemical identity

The FDA substance record identifies Nilotinib free base by CAS 641571-10-0 and UNII F41401512X and lists AMN-107 as a synonym. The TASIGNA label identifies the drug substance used in the finished capsules as nilotinib monohydrochloride monohydrate. The October 5, 2026 China CDE export has six related entries, all named 盐酸尼洛替尼 (nilotinib hydrochloride). The export does not identify the hydrate form of those entries.

Nilotinib free-base properties

The formula and molecular weight below describe the free base. When comparing specifications, check whether the assay is expressed as the free base or as the salt, and whether it is corrected for water content. Verify the stated hydrate or solid form against the intended material.

Molecular weight
529.5 g/mol
PubChem: Nilotinib (CID 644241)

Nilotinib API sourcing questions

What is the CAS number for Nilotinib free base?

The CAS number is 641571-10-0. FDA identifies this substance with UNII F41401512X. Use the CAS and stated chemical form together when requesting a material specification.

How does Nilotinib free base differ from nilotinib hydrochloride?

The hydrochloride pairs the protonated base with chloride. TASIGNA uses the monohydrochloride monohydrate and expresses capsule strength as the equivalent amount of anhydrous free base. The CDE name indicates the hydrochloride salt and gives no specific hydrate or CAS number. Those registrations are outside this free-base record set.

Which FDA DMF records are included?

The Q2 2026 workbook contains 4 Type II entries with NILOTINIB as the full subject after trimming. Type II also covers intermediates and finished drug products, so the subject is checked separately. The file gives no CAS field for independent confirmation.

What does an active Nilotinib DMF mean?

An A code indicates that the DMF was active in the FDA snapshot. FDA reviews the technical contents in connection with an application that references the DMF. The activity code does not indicate FDA approval or confirm that the holder will authorize a reference.

What should a buyer verify with a Nilotinib DMF holder?

Confirm the DMF number, the material form and assay basis, and the manufacturing site that would supply the intended batch. Request the applicable specification and batch certificate of analysis. If your application will reference the file, ask the holder about a letter of authorization.

FDA UNII: Nilotinib substance identityDailyMed: TASIGNA prescribing informationNMPA CDE API registry: October 5, 2026 exportFDA DMF list: Q2 2026 snapshotFDA: Types of Drug Master FilesFDA: Drug Master Files

Data sources

Official substance references, source snapshots and FDA guidance for interpreting the records.

FDA UNII: Nilotinib substance identity

Open source reference

U.S. Food and Drug Administration

Identifies the free base by its CAS number, UNII, formula and AMN-107 synonym.

View citation evidence

“641571-10-0”

U.S. Food and Drug Administration

Synonyms and Mappings in FDA UNII record F41401512X.

PubChem: Nilotinib (CID 644241)

Open source reference

National Center for Biotechnology Information

Supplies the free-base formula and computed molecular weight.

View citation evidence

“529.5 g/mol”

National Center for Biotechnology Information

Molecular Weight in the Computed Properties table for PubChem CID 644241.

DailyMed: TASIGNA prescribing information

Open source reference

U.S. National Library of Medicine

Describes the salt hydrate in the finished capsules and distinguishes it from the anhydrous free base used to express strength.

View citation evidence

“in the form of monohydrochloride monohydrate”

U.S. National Library of Medicine

Section 11, Description, of the TASIGNA prescribing information hosted by DailyMed.

FDA DMF list: Q2 2026 snapshot

Open source reference

U.S. Food and Drug Administration

The supplied workbook contains the selected filings at the June 30, 2026 cutoff. The official list page may show a newer quarter.

View citation evidence

“NILOTINIB”

U.S. Food and Drug Administration

Reported SUBJECT of the four selected Type II filings in worksheet 2Q2026-EXCEL.

FDA: Drug Master Files

Open source reference

U.S. Food and Drug Administration

Explains how DMFs can be referenced and how FDA reviews their contents alongside applications.

View citation evidence

“Are neither approved nor disapproved.”

U.S. Food and Drug Administration

FDA explanation of Drug Master Files and review of applications that reference them.

FDA: Types of Drug Master Files

Open source reference

U.S. Food and Drug Administration

Shows why Type II classification alone does not establish that a filing covers the free base.

View citation evidence

“Drug Substance, Drug Substance Intermediate”

U.S. Food and Drug Administration

FDA Type II Drug Master File category heading.

NMPA CDE API registry: October 5, 2026 export

Open source reference

Center for Drug Evaluation, National Medical Products Administration

The supplied export names all six related registrations as nilotinib hydrochloride.

View citation evidence

“盐酸尼洛替尼”

Center for Drug Evaluation, National Medical Products Administration

Reported substance name in the supplied eleven-column CDE API registry export.

Continue your Nilotinib API research

Use the free records to compare DMF holders and activity. Subscribe to search, filter and export the complete Nilotinib dataset from the supplied FDA snapshot.

Complete data requires an active subscription. Already subscribed? Sign in to access your data.

Report a data correction

Include the DMF number or field in question and a link to the supporting source.

Email APIRFQ support